Percentage of bloodstream infection due to methicillin-resistant in Czechia

Czechia: Percentage of bloodstream infection due to methicillin-resistant was 7.6% in 2022. ▼ Falling

Latest (2022)
7.6%
Change on year
down 19.0%
World rank
33rd
of 44 countries
All-time high
13.6%
in 2018
All-time low
7.6%
in 2022
Years of data
6
2017–2022

Percentage of bloodstream infection due to methicillin-resistant in Czechia, 2017–2022

0510152017201920222017: 13.22018: 13.62019: 12.52020: 9.32021: 9.42022: 7.6

Source: United Nations Statistics Division, SDG Global Database.

Analysis

In 2022, percentage of bloodstream infection due to methicillin-resistant in Czechia stood at 7.6%. That is the lowest value across all 6 years on record.

Compared with earlier readings it is down 19.0% on the previous year and down 42.1% over ten years.

Czechia ranks 33rd of 44 countries on this measure, in the middle of the range.

Percentage of bloodstream infection due to methicillin-resistant in Czechia, year by year

Annual values for Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%) in Czechia, 2017 to 2022.
Year Value Change
2017 13.2%
2018 13.6% +3.0%
2019 12.5% -7.9%
2020 9.3% -25.5%
2021 9.4% +1.1%
2022 7.6% -19.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 13.1% 12.5% 13.6% 3
2020s 8.8% 7.6% 9.4% 3

Countries ranked near Czechia

  1. 30 Ireland 10.5% compare
  2. 31 Lithuania 9.4% compare
  3. 32 United Kingdom of Great Britain and Northern Ireland 8.0% compare
  4. 34 Thailand 7.5% compare
  5. 35 Mozambique 6.7% compare
  6. 36 Luxembourg 4.7% compare

See the full ranking of 61 places →

More development goals data for Czechia

All data for Czechia →

Frequently asked questions

What is percentage of bloodstream infection due to methicillin-resistant in Czechia?
Percentage of bloodstream infection due to methicillin-resistant in Czechia was 7.6% in 2022, according to United Nations Statistics Division, SDG Global Database.
What is the highest percentage of bloodstream infection due to methicillin-resistant recorded in Czechia?
The highest recorded value was 13.6% in 2018.
What is the lowest percentage of bloodstream infection due to methicillin-resistant recorded in Czechia?
The lowest recorded value was 7.6% in 2022.
How does Czechia rank for percentage of bloodstream infection due to methicillin-resistant?
Czechia ranks 33rd out of 44 countries with data for 2022.
Is percentage of bloodstream infection due to methicillin-resistant rising or falling in Czechia?
Over the last ten years it is down 42.1%. The long-run trend across the full record is falling.
Where does this Czechia data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 6 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Percentage of bloodstream infection due to methicillin-resistant in Czechia. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 31 August 2026, from https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/czechia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/czechia/">Percentage of bloodstream infection due to methicillin-resistant in Czechia</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
61 places, 372 data points, 2016–2022
Last refreshed